Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis
- 24 July 2021
- journal article
- review article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 44 (7) , 725-740
Abstract
Anecdotal evidence suggests that the severity of coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is likely to be distinguished by variations in loss of smell (LOS). Thus, we conducted a meta-analysis of 45 articles that include a total of 42,120 COVID-19 patients from 17 different countries to demonstrate that severely ill or hospitalized COVID-19 patients have a lesser chance of experiencing LOS than non-severely ill or non-hospitalized COVID-19 patients (odds ratio = 0.527 [95% CI 0.373–0.744; p < 0.001] and 0.283 [95% CI 0.173–0.462; p < 0.001], respectively). We also proposed a possible mechanism underlying the association of COVID-19 severity with anosmia, which may explain why patients without sense of smell develop severe COVID-19. Variations in LOS according to the severity of COVID-19 is a global phenomenon, with few exceptions. Since severely ill patients have a lower rate of anosmia, patients without anosmia should be monitored more closely in the early stages of COVID-19, for early diagnosis of severity of illness. An understanding of how the severity of COVID-19 infection and LOS are associated has profound implications for the clinical management and mitigation strategies for the disease.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2015R1A5A1008958)
- Ministry of Education (2018R1D1A1B07046564)
- National Research Foundation of Korea (2021R1A6A1A03044296)
This publication has 84 references indexed in Scilit:
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Viral dynamics in mild and severe cases of COVID-19The Lancet Infectious Diseases, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Olfactory sensory neurons mediate ultrarapid antiviral immune responses in a TrkA-dependent mannerProceedings of the National Academy of Sciences, 2019
- The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous systemThe Journal of Pathology, 2014
- Measuring inconsistency in meta-analysesBMJ, 2003
- Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosisJournal of General Virology, 2002
- Local mucociliary defence mechanismsPaediatric Respiratory Reviews, 2000
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997